(Bristol/Theradex) A phase II trial of paclitaxel (taxol) administered as a weekly one hour infusion in previously treated patients with head and neck cancers,
Role: Investigator,
Bristol-Myers Squibb Foundation, Inc.,
(10/2000 - 10/2001)
Status: Completed